Outcomes at 10-Year Follow-Up after Roux-en-Y Gastric Bypass, Biliopancreatic Diversion, and Sleeve Gastrectomy
- PMID: 37568375
- PMCID: PMC10419540
- DOI: 10.3390/jcm12154973
Outcomes at 10-Year Follow-Up after Roux-en-Y Gastric Bypass, Biliopancreatic Diversion, and Sleeve Gastrectomy
Abstract
Introduction: Morbid obesity is a well-defined chronic disease, the incidence of which is constantly rising. Surgical treatment of morbid obesity has produced superior outcomes compared to conventional weight loss measures. Currently, there is a gap in the literature regarding long-term outcomes. Our single-institution, retrospective cohort study aims to evaluate weight loss outcomes, comorbidity reduction, and adverse effects at 10 years following Roux-en-Y Gastric Bypass (RYGB), Biliopancreatic Diversion (BPD), and Sleeve Gastrectomy (SG).
Materials and methods: We included all consecutive patients with 10-year follow-up records operated on within our institution. The comparison was carried out on the average percentage of weight and BMI loss. Nausea and vomiting were evaluated through self-reporting Likert scales. Diabetes resolution and nutritional deficiencies were also evaluated.
Results: A total of 490 patients from 1995 up to 2011 were included in our study. Of these, 322 underwent RYGB, 58 underwent long-limb BPD, 34 underwent laparoscopic RYGB with fundus excision, 47 underwent laparoscopic SG, and 29 underwent laparoscopic RYGB as a revision of prior SG. RYGB and BPD were significantly associated with higher percentages of weight loss (37.6% and 37.5%), but were not found to be independent predictors of weight loss. Nausea and vomiting were associated with SG and laparoscopic RYGB with fundus excision, more so than the other operations. No differences were observed regarding diabetes resolution and nutritional deficiencies.
Conclusions: Longer follow-up reports are important for the comparison of outcomes between different types of bariatric operations. BPD and RYGB resulted in superior weight loss, with no observed differences in diabetes resolution and adverse outcomes.
Keywords: Roux-en-Y bypass; gastric bypass; morbid obesity; obesity surgery; sleeve gastrectomy.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Mechanick J.I., Youdim A., Jones D.B., Garvey W.T., Hurley D.L., McMahon M.M., Heinberg L.J., Kushner R., Adams T.D., Shikora S., et al. Clinical Practice Guidelines for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient—2013 Update: Cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity. 2013;9:159–191. doi: 10.1002/OBY.20461. - DOI - PubMed
-
- Eisenberg D., Shikora S.A., Aarts E., Aminian A., Angrisani L., Cohen R.V., De Luca M., Faria S.L., Goodpaster K.P.S., Haddad A., et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg. Obes. Relat. Dis. 2022;18:1345–1356. doi: 10.1016/j.soard.2022.08.013. - DOI - PubMed
-
- Mechanick J.I., Apovian C., Brethauer S., Garvey W.T., Joffe A.M., Kim J., Kushner R.F., Lindquist R., Pessah-Pollack R., Seger J., et al. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures—2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Surg. Obes. Relat. Dis. 2020;16:175–247. doi: 10.1016/J.SOARD.2019.10.025. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
